SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event

    • Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company

      SOPHiA GENETICS’ next-generation solution CarePath, fueled by current real world observational data, was previewed for attendees

      BOSTON and GENEVA, Switzerland, Sept. 21, 2022 (PR NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, hosted its first-ever Investor Day on Tuesday, September 20, 2022, in New York City.